SIRT3 and SIRT5 also mediate desuccinylation and deacetylation of SHMT2, respectively, suggesting that suppression of serine catabolism might represent a novel strategy to restrain tumor growth (Wei et al., 2018; Yang et al., 2018). Here, SHMT2 is linked to neoplasm.